768 Peroxiredoxin-1 Protects Against Oncogene-induced Suppression of the Estrogen Receptor and is a Biomarker of Favourable Prognosis in Estrogen Receptor-positive Breast Cancer

Authors :: K. Jirstrom
Radoslaw Zagozdzon
W. M. Gallagher
Fredrik Pontén
Gordon B. Mills
Bryan T. Hennessy
Darran P. O'Connor
D. J. Brennan
Patrick O’Leary
A. M. Gonzalez-Angulo
Source :: European Journal of Cancer. 48:S182
Publication Year :: 2012
Publisher :: Elsevier BV, 2012.
Abstract: Peroxiredoxin-1 Protects Against Oncogene-induced Suppression of the Estrogen Receptor and is a Biomarker of Favourable Prognosis in Estrogen Receptor-positive Breast Cancer

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Oncogene
medicine.drug_class
business.industry
Estrogen receptor
respiratory system
Peroxiredoxin 1
medicine.disease
Breast cancer
Estrogen
Internal medicine
medicine
Biomarker (medicine)
business
hormones, hormone substitutes, and hormone antagonists

Tools